Alps Advisors Inc Dexcom Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Dexcom Inc stock. As of the latest transaction made, Alps Advisors Inc holds 13,042 shares of DXCM stock, worth $989,626. This represents 0.01% of its overall portfolio holdings.

Number of Shares

13,042

Previous 11,795 10.57%

Holding current value

$989,626

Previous $1.34 Million 34.63%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$64.0 - $116.06 $79,808 - $144,726	1,247 Added 10.57%	13,042 $874,000
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $66,075 - $84,129	599 Added 5.35%	11,795 $1.34 Million
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $58,366 - $71,591	-511 Reduced 4.36%	11,196 $1.55 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $88,323 - $145,267	-1,170 Reduced 9.09%	11,707 $1.45 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $65,663 - $105,240	763 Added 6.3%	12,877 $1.2 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $135,638 - $157,961	-1,206 Reduced 9.05%	12,114 $1.56 Million
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $416,416 - $492,171	4,004 Added 42.98%	13,320 $1.55 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $387,763 - $559,743	-4,563 Reduced 32.88%	9,316 $1.05 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $348,232 - $429,554	-4,561 Reduced 24.73%	13,879 $1.12 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $972,596 - $1.9 Million	14,305 Added 345.95%	18,440 $1.37 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $79,591 - $110,149	-846 Reduced 16.98%	4,135 $2.12 Million
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $16,883 - $21,166	-130 Reduced 2.54%	4,981 $2.68 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $53,355 - $71,590	-500 Reduced 8.91%	5,111 $2.8 Million
Q2 2021 Aug 11, 2021	SELL	$80.99 - $107.93 $3,725 - $4,964	-46 Reduced 0.81%	5,611 $2.4 Million
Q1 2021 May 07, 2021	BUY	$84.79 - $104.74 $16,618 - $20,529	196 Added 3.59%	5,657 $2.03 Million
Q4 2020 Feb 03, 2021	BUY	$78.0 - $104.5 $32,058 - $42,949	411 Added 8.14%	5,461 $2.02 Million
Q3 2020 Nov 04, 2020	BUY	$95.51 - $112.95 $16,141 - $19,088	169 Added 3.46%	5,050 $2.08 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $68,885 - $115,768	1,099 Added 29.06%	4,881 $1.98 Million
Q1 2020 May 06, 2020	BUY	$47.79 - $75.63 $1,481 - $2,344	31 Added 0.83%	3,782 $1.02 Million
Q4 2019 Feb 07, 2020	SELL	$36.62 - $57.29 $34,166 - $53,451	-933 Reduced 19.92%	3,751 $820,000
Q3 2019 Nov 04, 2019	SELL	$35.53 - $43.8 $3,375 - $4,161	-95 Reduced 1.99%	4,684 $699,000
Q2 2019 Aug 07, 2019	BUY	$27.84 - $38.92 $31,180 - $43,590	1,120 Added 30.61%	4,779 $716,000
Q1 2019 May 01, 2019	BUY	$28.07 - $38.18 $3,536 - $4,810	126 Added 3.57%	3,659 $436,000
Q4 2018 Feb 04, 2019	SELL	$26.99 - $37.37 $1,025 - $1,420	-38 Reduced 1.06%	3,533 $423,000
Q3 2018 Oct 25, 2018	BUY	$23.35 - $36.72 $6,211 - $9,767	266 Added 8.05%	3,571 $511,000
Q2 2018 Aug 02, 2018	BUY	$17.54 - $25.22 $57,969 - $83,352	3,305 New	3,305 $314,000

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Dexcom Inc Transaction History